Table 2. Comparison of baseline geometric means of serum carotenoid levels between those who died and survivors.
| Serum carotenoids | Sex | Alive* | Cardiovascular death† | Heart disease death† | Stroke death† |
|
α-carotene (μmol/L) |
Males | 0.106 | 0.090 (0.076) | 0.081 (0.034) | 0.095 (0.391) |
| Females | 0.166 | 0.146 (0.190) | 0.147 (0.370) | 0.145 (0.371) | |
|
β-carotene (μmol/L) |
Males | 0.425 | 0.388 (0.400) | 0.413 (0.876) | 0.356 (0.235) |
| Females | 0.969 | 0.759 (0.025) | 0.864 (0.461) | 0.679 (0.033) | |
| Lycopene (μmol/L) |
Males | 0.258 | 0.221 (0.142) | 0.237 (0.607) | 0.194 (0.056) |
| Females | 0.371 | 0.327 (0.304) | 0.248 (0.017) | 0.424 (0.539) | |
| Total carotene (μmol/L) |
Males | 0.848 | 0.750 (0.168) | 0.789 (0.591) | 0.685 (0.091) |
| Females | 1.587 | 1.321 (0.057) | 1.343 (0.214) | 1.296 (0.172) | |
| n | Males | 1140 | 49 | 24 | 24 |
| Females | 1839 | 31 | 16 | 13 | |
P values calculated using ANOVA after controlling for age in parentheses
Serum levels of total carotenes calculated as the sum of α-carotene, β-carotene, and lycopene levels.
Each serum level of carotenoids was transformed logarithmically.
* : The inhabitants who did not die of cardiovascular disease during follow-up
† : The inhabitants who died of each disease during follow-up